Zeke Capital Advisors, LLC Bio Rad Laboratories, Inc. Transaction History

Zeke Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $43,321 - $59,142	-105 Reduced 9.08%	1,052 $439,000
Q2 2022 Aug 09, 2022	BUY	$463.67 - $597.16 $166,921 - $214,977	360 Added 45.17%	1,157 $573,000
Q1 2022 May 13, 2022	BUY	$524.57 - $735.42 $418,082 - $586,129	797 New	797 $449,000
Q4 2018 Feb 11, 2019	SELL	$220.1 - $309.0 $1.01 Million - $1.42 Million	-4,583 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$289.28 - $326.15 $1.33 Million - $1.49 Million	4,583 New	4,583 $1.43 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.